Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adagene
Biotech
Merck KGaA lands new R&D chief—Chutes & Ladders
Merck KGaA lands new R&D chief. Cartography maps expanded leadership team. Psychedelic CEO steps down.
Darren Incorvaia
,
Zoey Becker
Sep 5, 2025 8:30am
Sanofi takes up option on Adagene bispecific, invests $25M
Jul 1, 2025 8:10am
ADC Therapeutics calls it quits on Adagene solid tumor collab
Aug 31, 2023 10:24am
Sanofi looks for a 'safe' bet in $2.5B tie up for Adagene tech
Mar 2, 2022 6:00am
Adagene plans $125M IPO to challenge BMS and Pfizer
Jan 20, 2021 9:00am
China's Adagene bags $69M to advance lead immunotherapies
Jan 8, 2020 7:30am